A. Santucci

发表

The ISCHEMIA trial: optimal medical therapy against PTCA in the stable patient: the endless story

C. Cavallini, A. Santucci, 2021, European heart journal supplements : journal of the European Society of Cardiology.

Impact of chronic kidney disease on 2‐year clinical outcomes in patients treated with 6‐month or 24‐month DAPT duration: An analysis from the PRODIGY trial

S. Windecker, M. Valgimigli, R. Piccolo, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial.

P. Jüni, S. Windecker, M. Valgimigli, 2021, European heart journal. Acute cardiovascular care.

Digital Gangrene Following Transradial Coronary Angiogram.

M. Valgimigli, A. Santucci, 2016, JACC. Cardiovascular interventions.

Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry

Massimo Siviglia, J. Mehilli, G. De Luca, 2021, Atherosclerosis.

Radial versus femoral approach in STEMI: what do we know so far?

M. Valgimigli, R. Piccolo, G. Magnani, 2016, Minerva cardioangiologica.

Treatment of stable ischaemic heart disease: the old and the new

Andrea Santucci, C. Cavallini, Clara Riccini, 2020, European heart journal supplements : journal of the European Society of Cardiology.

The ISCHEMIA trial: optimal medical therapy against PTCA in the stable patient: the endless story

Andrea Santucci, C. Cavallini, A. Santucci, 2021, European heart journal supplements : journal of the European Society of Cardiology.

Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention

S. de Servi, S. Coiro, Andrea Santucci, 2021, Clinical chemistry and laboratory medicine.

Bivalirudin in Acute Coronary Syndromes. Authors reply.

M. Valgimigli, A. Santucci, Rahman Shah, 2016, The New England journal of medicine.

Favorable effects of intravenous beta blockers in ST elevation myocardial infarct: time for a revival?

Andrea Santucci, C. Cavallini, A. Santucci, 2018, Journal of cardiovascular medicine.

Clinical approach on challenge and desensitization procedures with aspirin in patients with ischemic heart disease and NSAID hypersensitivity

Lippolis, L. Losappio, P. Bonadonna, 2016 .

Cardiac complications of COVID-19 vaccination: now we know more

S. Coiro, P. Verdecchia, F. Angeli, 2022, European heart journal supplements : journal of the European Society of Cardiology.

Appraising the safety and efficacy profile of left atrial appendage closure in 2016 and the future clinical perspectives. Results of the EAPCI LAAC survey.

A. Baumbach, S. Windecker, M. Valgimigli, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI

Massimo Siviglia, J. Mehilli, D. Dudek, 2020, Journal of the American College of Cardiology.

Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease: A Subgroup Analysis of the PRODIGY Randomized Clinical Trial.

S. Windecker, M. Valgimigli, R. Piccolo, 2016, JAMA cardiology.

Primary and secondary prevention in diabetic patients: are we not aggressive enough?

C. Cavallini, A. Murrone, A. Santucci, 2017, Journal of cardiovascular medicine.

Use of the Dual-Antiplatelet Therapy Score to Guide Treatment Duration After Percutaneous Coronary Intervention

S. Windecker, M. Valgimigli, R. Piccolo, 2017, Annals of Internal Medicine.

Therapy of Type 2 diabetes: more gliflozines and less metformin?

S. Coiro, P. Verdecchia, F. Angeli, 2023, European heart journal supplements : journal of the European Society of Cardiology.

Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry

G. De Luca, C. von Birgelen, G. Galasso, 2021, Biomedicine & Pharmacotherapy.

Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial.

S. Windecker, M. Valgimigli, R. Piccolo, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of Sex on 2-Year Clinical Outcomes in Patients Treated With 6-Month or 24-Month Dual-Antiplatelet Therapy Duration: A Pre-Specified Analysis From the PRODIGY Trial.

S. Windecker, M. Valgimigli, R. Piccolo, 2016, JACC. Cardiovascular interventions.

Interpretation of Ambulatory Blood Pressure Monitoring for Risk Stratification in Hypertensive Patients: The ‘Ambulatory Does Prediction Valid (ADPV)’ Approach

S. Coiro, G. Reboldi, P. Verdecchia, 2023, Diagnostics.

Predictors of in-hospital and long-term mortality in unselected patients admitted to a modern coronary care unit

P. Verdecchia, Claudia Castellani, R. Annunziata, 2019, Journal of cardiovascular medicine.

Catheter-based renal artery denervation: facts and expectations.

P. Verdecchia, F. Angeli, C. Cavallini, 2023, European journal of internal medicine.

The myocardial bridge: incidence, diagnosis, and prognosis of a pathology of uncertain clinical significance

C. Cavallini, Sara Cavallini, F. Jacoangeli, 2022, European heart journal supplements : journal of the European Society of Cardiology.

Impact of Sex on 2-Year Clinical Outcomes in Patients Treated With 6-Month or 24-Month Dual-Antiplatelet Therapy Duration A Pre-Speci ﬁ ed Analysis From the PRODIGY Trial

M. Valgimigli, R. Piccolo, A. Franzone, 2022 .